Curevac N.V. (CVAC) SEC Filing 6-K Foreign Issuer Report for the period ending Thursday, February 10, 2022

Curevac N.V.

CIK: 1809122 Ticker: CVAC

View differences made from one to another to evaluate Curevac N.V.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Curevac N.V..


Assess how Curevac N.V.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Curevac N.V.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Curevac N.V. provided additional information to their SEC Filing as exhibits

Ticker: CVAC
CIK: 1809122
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001104659-22-017655
Submitted to the SEC: Thu Feb 10 2022 8:13:58 AM EST
Accepted by the SEC: Thu Feb 10 2022
Period: Thursday, February 10, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: